恶性质瘤瘤病毒治疗的临床进展:系统性审查
Shan Jiang1,2,3,4, Huihui Chai1,2,3,4, Qisheng Tang1,2,3,4
1National Center for Neurological Disorders, Shanghai, China.
Discover oncology
|October 16, 2023
概括
瘤消毒病毒 (OV) 治疗对恶性质瘤治疗具有前景,显示出可能在没有严重副作用的情况下延长存活时间. 需要对最佳的OV应用策略进行进一步的研究,以改善临床结果.
科学领域:
- 神经瘤学神经瘤学
- 病毒学 病毒学
- 临床试验 临床试验
背景情况:
- 恶性质瘤治疗在过去十年中取得的进展有限.
- 瘤病毒 (OV) 已成为质瘤的有希望的治疗策略.
- 临床试验表明OV疗法有可能延长质瘤患者的存活时间.
研究的目的:
- 系统地评估瘤治疗病毒 (OV) 治疗恶性质瘤的有效性和安全性.
- 分析已发表的关于OV治疗质瘤的临床试验数据.
主要方法:
- 对已公布的临床试验进行了系统审查,截至2023年1月16日.
- 搜索包括英语和中文的"结质瘤"",结质母细胞瘤"和"瘤病毒"等术语.
- 数据提取集中在19个选定的试验的生存结果和不良事件上.
主要成果:
- 分析了19项涉及对恶性质瘤进行OV治疗的临床试验.
- 没有报告与治疗相关的不可抗拒的不良反应.
- 平均整体存活时间在3.25至20.2个月之间.
- 根据IDH或MGMT分子状态,OV治疗的有效性没有显著差异.
结论:
- 瘤性病毒疗法代表了恶性质瘤的潜在新治疗方式.
- 未来的临床应用需要优化策略,包括病毒开发,施用时间表,药物输送系统和生物标志物.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Cancer Vaccines
383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383